| Bioactivity | Ralfinamide (FCE-26742A) is an orally available Na+ blocker derived from α-aminoamide, with function of suppressing pain[1][2]. | ||||||||||||
| Target | Na+channel | ||||||||||||
| In Vivo | Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain[1]. Animal Model: | ||||||||||||
| Name | Ralfinamide | ||||||||||||
| CAS | 133865-88-0 | ||||||||||||
| Formula | C17H19FN2O2 | ||||||||||||
| Molar Mass | 302.34 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Zhang SH, et al. Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat. Pain. 2008 Oct 15;139(2):293-305. [2]. Liang X, et al. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain. Eur J Pharmacol. 2018 Mar 15;823:27-34. |
Ralfinamide
CAS: 133865-88-0 F: C17H19FN2O2 W: 302.34
Ralfinamide (FCE-26742A) is an orally available Na+ blocker derived from α-aminoamide, with function of suppressing pai
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.